We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 60

EU institutions agree text of new Medical Devices legislation
  • CMS Cameron McKenna Nabarro Olswang LLP
  • European Union
  • May 27 2016

On Wednesday 25 May the EU institutions reached agreement on the draft texts for the revised Medical Devices Regulation and In Vitro Diagnostics


Clearcast not subject to Judicial Review
  • CMS Cameron McKenna Nabarro Olswang LLP
  • United Kingdom
  • May 19 2016

In an important decision for all UK advertisers, but especially those advertising medical devices, the High Court has found that Clearcast is not


The Antidote - Winter 2015
  • CMS Cameron McKenna Nabarro Olswang LLP
  • OECD, European Union
  • December 4 2015

The intended two new EU Regulations, one for devices and one for diagnostics, will replace the current three Directives. A series of fi ve blocks of


Revision of the EU medical device legislation enters trilogue negotiations
  • CMS Cameron McKenna Nabarro Olswang LLP
  • European Union
  • October 19 2015

Negotiations between the European Parliament, European Council and European Commission to agree on the proposed revision of the EU medical devices


UK proposes a "Sunshine Rule" for 2016 to improve transparency between NHS healthcare professionals and industry
  • CMS Cameron McKenna Nabarro Olswang LLP
  • United Kingdom
  • August 27 2015

The Secretary of State for Health has proposed implementing a rule requiring NHS healthcare organisations to keep registers of any gifts that their


ASA adjudications snapshot April 2015
  • CMS Cameron McKenna Nabarro Olswang LLP
  • United Kingdom
  • May 29 2015

A TV ad promoted a topically applied gel used to relieve joint pain, stating it was “Drug Free” and “doesn’t contain any drugs”. The complainant, a GP


Ukraine cancelled VAT and additional import duty on certain medicines
  • CMS Cameron McKenna Nabarro Olswang LLP
  • Ukraine
  • May 21 2015

In March 2015 Ukraine began allowing state procurement of certain medicines and medical devices to be conducted via international organizations such


Revision of the Swiss Therapeutic Products Act
  • CMS Cameron McKenna Nabarro Olswang LLP
  • Switzerland
  • February 20 2015

As at the start of 2015, three different versions exist of the revised Swiss Therapeutic Products Act, which will change the law on discounts and


Proposed changes to the Eucomed Code
  • CMS Cameron McKenna Nabarro Olswang LLP
  • European Union
  • February 20 2015

Medical device and IVD companies subscribing to the Eucomed or counterpart national business ethics Codes will have to start preparations to cease


Under the microscope - how 2014’s legal developments could affect lifescience businesses in Europe in 2015
  • CMS Cameron McKenna Nabarro Olswang LLP
  • European Union
  • February 18 2015

The challenging European austerity market has continued throughout 2014 with increased member state focus on prices even to the point where this